Table 2.

Multivariate analysis of disease-free and overall survival of stage B2 and C patients treated with adjuvant chemotherapy

Category	B2 (n = 83)				C (n = 120)
	Disease-free survival		Overall survival		Disease-free survival		Overall survival
	Hazard ratio (95% Cl)	p	Hazard ratio (95% Cl)	p	Hazard ratio (95% Cl)	p	Hazard ratio (95% Cl)	p
Sex	0.97 (0.37–2.53)	0.95	0.99 (0.24–4.04)	0.99	1.21 (0.71–2.08)	0.49	1.50 (0.73–3.05)	0.27
Age	0.99 (0.95–1.03)	0.63	1.00 (0.94–1.07)	0.99	1.02 (0.99–1.05)	0.12	1.02 (0.99–1.05)	0.29
Grade	0.56 (0.20–1.57)	0.27	0.39 (0.08–1.86)	0.24	1.93 (1.12–3.33)	0.018	2.87 (1.37–6.01)	0.005
Tumor site	0.99 (0.29–3.47)	0.10	2.55 (0.64–10.15)	0.19	0.57 (0.27–1.17)	0.13	0.35 (0.10–1.15)	0.08
P21WAF1	0.36 (0.14–0.93)	0.035	0.16 (0.03–0.76)	0.02	0.60 (0.35–1.04)	0.07	0.48 (0.24–0.93)	0.03